← Back to Search

ERAS Anesthesia Techniques for Knee Surgery Recovery (EKAT-TeleTPS Trial)

N/A
Recruiting
Led By David Kim, MD
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Planned use of regional anesthesia
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operative day 1-2 (24-48 hours post spinal induction)
Awards & highlights

EKAT-TeleTPS Trial Summary

This trial compares two different ways of numbing the area around the knee during surgery.

Who is the study for?
This trial is for English-speaking adults aged 18-65 with osteoarthritis, scheduled for knee replacement surgery using regional anesthesia. They must live within an hour of the hospital, be able to follow the study protocol, have a smartphone, and have home caregivers if needed. Excluded are those with diabetes, chronic pain or high pain catastrophizing scores, severe knee deformities, no home caregivers for catheter care, ASA status III/IV patients, those unable to manage a catheter at home or going to rehab facilities post-surgery.Check my eligibility
What is being tested?
The trial compares two anesthesia techniques in knee replacements: one uses a single-shot nerve block plus local injections (PAI & IPACK), while the other adds a continuous nerve block through a catheter (ACC). The goal is to see which method provides better pain control during recovery.See study design
What are the potential side effects?
Potential side effects may include discomfort at the injection site(s), possible infection risk from the catheter placement for continuous nerve blocks and potential numbness or weakness in the leg temporarily due to nerve blocks.

EKAT-TeleTPS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are scheduled to receive regional anesthesia during the study.

EKAT-TeleTPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operative day 1-2 (24-48 hours post spinal induction)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-operative day 1-2 (24-48 hours post spinal induction) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opioid consumption during 24-48 hour period
Secondary outcome measures
Opioid consumption during post-anesthesia care unit (PACU) stay

EKAT-TeleTPS Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Continuous Adductor Canal Catheter (ACC)Active Control1 Intervention
Patients will receive a combined spinal epidural, PAI, IPACK, and a continuous adductor canal catheter
Group II: Adductor Canal block with sham catheterPlacebo Group1 Intervention
Patients will receive a combined spinal epidural, PAI, IPACK, and an adductor canal block. The patient will also receive a sham catheter.

Find a Location

Who is running the clinical trial?

Hospital for Special Surgery, New YorkLead Sponsor
242 Previous Clinical Trials
61,808 Total Patients Enrolled
David Kim, MDPrincipal InvestigatorHospital for Special Surgery, New York
1 Previous Clinical Trials
112 Total Patients Enrolled

Media Library

Adductor Canal block with sham catheter Clinical Trial Eligibility Overview. Trial Name: NCT03747146 — N/A
Anesthesia Research Study Groups: Continuous Adductor Canal Catheter (ACC), Adductor Canal block with sham catheter
Anesthesia Clinical Trial 2023: Adductor Canal block with sham catheter Highlights & Side Effects. Trial Name: NCT03747146 — N/A
Adductor Canal block with sham catheter 2023 Treatment Timeline for Medical Study. Trial Name: NCT03747146 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation currently allow for participant enrollment?

"Affirmative. According to the information accessible on clinicaltrials.gov, this clinical trial posted in November 16th 2018 is currently recruiting participants. The goal is to recruit 94 patients at one site before April 12th 2022."

Answered by AI

What is the current capacity for enrollment in this clinical trial?

"Affirmative. The information on clinicaltrials.gov supports the contention that this medical trial is actively recruiting participants. This study was first published on November 16th 2018, and has most recently been updated April 12th 2022 - with a recruitment target of 94 patients at 1 site."

Answered by AI

Does the clinical trial encompass individuals over a certain age threshold?

"This research initiative is open to participants aged between 18 and 65."

Answered by AI

Does my profile meet the requirements of this research project?

"According to the study's eligibility criteria, potential participants must have had prior anaesthesia treatment and lie within the ages of majority and seniority. The total amount of accepted individuals is anticipated to be 94 in number."

Answered by AI
~22 spots leftby Dec 2025